Hongwei Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongwei Zhu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Tao Du
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
8 shared publicationsYunjian Huang
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
6 shared publicationsShiyun Xu
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
5 shared publicationsSiyi Liu
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
5 shared publicationsBing Ni
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
4 shared publications- Bing Ni
Xuanwu Hospital, Capital Medical University, Beijing 100053, China
4 shared publications
Latest Publications
- 16 October 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 155, 112341
Image-guided modified Hartel approach for percutaneous balloon compression in treating trigeminal neuralgia: a comparative cohort study
- 16 October 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 155, 112341
Image-guided modified Hartel approach for percutaneous balloon compression in treating trigeminal neuralgia: a comparative cohort study
- Open Access
- 16 September 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 978
Early Risk Stratification and Time-to-Cure Analysis in Patients with Residual Hemifacial Spasm After Microvascular Decompression
Background/Objectives: Microvascular decompression (MVD) is an effective treatment for hemifacial spasm (HFS), but some patients have residual spasms after surgery. Some later achieve delayed cure, whereas others have persistent HFS, making reoperation planning difficult. This study aimed to develop a prediction model for early risk stratification in patients with residual HFS after MVD. Methods: We retrospectively analyzed 500 consecutive patients with primary HFS who underwent MVD between November 2021 and August 2023. Among them, 140 patients with residual HFS at 24 h postoperatively were included. Clinical variables, intraoperative abnormal muscle response, Cohen grade at 24 h after surgery (Cohen-post), and Immediate Subjective Improvement Rate (ISIR) were collected. A multivariable logistic regression model was developed and presented as a nomogram, with bootstrap internal validation. Cox regression and Kaplan–Meier analyses were used to assess time to cure. Results: Mean follow-up was 21.9 months. Delayed cure occurred in 102 patients (72.9%), whereas 38 (27.1%) had persistent HFS. The final model included ISIR, Cohen-post, and offending artery status. The nomogram showed good discrimination (area under the curve 0.901). Patients with higher ISIR and lower Cohen-post recovered faster. Among patients with delayed cure, median time to cure was 30 days, and 95% achieved cure within 300 days after surgery. Conclusions: In patients with residual HFS at 24 h after MVD, a nomogram incorporating ISIR, Cohen-post, and offending artery status may help distinguish delayed cure from persistent HFS and may provide useful information on the likelihood of further recovery.
- 16 September 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (9) , 978
Open AccessEarly Risk Stratification and Time-to-Cure Analysis in Patients with Residual Hemifacial Spasm After Microvascular Decompression
Background/Objectives: Microvascular decompression (MVD) is an effective treatment for hemifacial spasm (HFS), but some patients have residual spasms after surgery. Some later achieve delayed cure, whereas others have persistent HFS, making reoperation planning difficult. This study aimed to develop a prediction model for early risk stratification in patients with residual HFS after MVD. Methods: We retrospectively analyzed 500 consecutive patients with primary HFS who underwent MVD between November 2021 and August 2023. Among them, 140 patients with residual HFS at 24 h postoperatively were included. Clinical variables, intraoperative abnormal muscle response, Cohen grade at 24 h after surgery (Cohen-post), and Immediate Subjective Improvement Rate (ISIR) were collected. A multivariable logistic regression model was developed and presented as a nomogram, with bootstrap internal validation. Cox regression and Kaplan–Meier analyses were used to assess time to cure. Results: Mean follow-up was 21.9 months. Delayed cure occurred in 102 patients (72.9%), whereas 38 (27.1%) had persistent HFS. The final model included ISIR, Cohen-post, and offending artery status. The nomogram showed good discrimination (area under the curve 0.901). Patients with higher ISIR and lower Cohen-post recovered faster. Among patients with delayed cure, median time to cure was 30 days, and 95% achieved cure within 300 days after surgery. Conclusions: In patients with residual HFS at 24 h after MVD, a nomogram incorporating ISIR, Cohen-post, and offending artery status may help distinguish delayed cure from persistent HFS and may provide useful information on the likelihood of further recovery.
- Open Access
- 7 September 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1955515
Long-term outcomes of spinal cord stimulation for refractory phantom limb pain
Objectives: Phantom limb pain (PLP) is a disabling post-amputation neuropathic pain condition, and evidence regarding the long-term effectiveness of spinal cord stimulation (SCS) remains limited. This study evaluated trial stimulation outcomes, pain trajectories, device retention, explantation, and device-related complications in patients with refractory PLP. Methods: We retrospectively reviewed 28 patients with refractory PLP who underwent SCS trial stimulation at our center between June 2010 and September 2023. Baseline characteristics, procedural data, Numeric Rating Scale (NRS) scores, progression to permanent implantation, revision or replacement procedures, and device explantation were recorded. Changes in NRS scores from baseline were assessed, and exploratory regression analyses were performed. Results: Eighteen patients (64%) met the criteria for trial success and proceeded to permanent SCS implantation. In an exploratory analysis, a higher baseline NRS score was associated with trial success. Among the 18 patients with permanent implants, the median follow-up was 78 months. Five SCS systems (28%) were explanted: three because of inadequate pain relief and two after battery depletion without replacement. In a post hoc analysis of the 13 patients who retained their devices at the last available follow-up, the mean NRS score decreased from 8.9 ± 0.8 at baseline to 2.8 ± 0.7 after trial stimulation and was 4.8 ± 0.6 at 1 year, 5.6 ± 1.0 at 2 years, and 6.2 ± 1.1 at the last available follow-up. Three patients underwent planned IPG replacement because of battery depletion, and two underwent unplanned device-related revision procedures. Conclusions: SCS provided substantial short-term pain relief in selected patients with refractory PLP. However, the magnitude of pain relief diminished over time, and device explantation occurred in a substantial minority of patients, underscoring the need for careful patient selection, long-term follow-up, and device management.
- 7 September 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1955515
Open AccessLong-term outcomes of spinal cord stimulation for refractory phantom limb pain
Objectives: Phantom limb pain (PLP) is a disabling post-amputation neuropathic pain condition, and evidence regarding the long-term effectiveness of spinal cord stimulation (SCS) remains limited. This study evaluated trial stimulation outcomes, pain trajectories, device retention, explantation, and device-related complications in patients with refractory PLP. Methods: We retrospectively reviewed 28 patients with refractory PLP who underwent SCS trial stimulation at our center between June 2010 and September 2023. Baseline characteristics, procedural data, Numeric Rating Scale (NRS) scores, progression to permanent implantation, revision or replacement procedures, and device explantation were recorded. Changes in NRS scores from baseline were assessed, and exploratory regression analyses were performed. Results: Eighteen patients (64%) met the criteria for trial success and proceeded to permanent SCS implantation. In an exploratory analysis, a higher baseline NRS score was associated with trial success. Among the 18 patients with permanent implants, the median follow-up was 78 months. Five SCS systems (28%) were explanted: three because of inadequate pain relief and two after battery depletion without replacement. In a post hoc analysis of the 13 patients who retained their devices at the last available follow-up, the mean NRS score decreased from 8.9 ± 0.8 at baseline to 2.8 ± 0.7 after trial stimulation and was 4.8 ± 0.6 at 1 year, 5.6 ± 1.0 at 2 years, and 6.2 ± 1.1 at the last available follow-up. Three patients underwent planned IPG replacement because of battery depletion, and two underwent unplanned device-related revision procedures. Conclusions: SCS provided substantial short-term pain relief in selected patients with refractory PLP. However, the magnitude of pain relief diminished over time, and device explantation occurred in a substantial minority of patients, underscoring the need for careful patient selection, long-term follow-up, and device management.
- Open Access
- 30 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Deep brain stimulation ameliorates social deficits from early-life pain by restoring excitatory/inhibitory balance in the anterior cingulate cortex
- 30 July 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessDeep brain stimulation ameliorates social deficits from early-life pain by restoring excitatory/inhibitory balance in the anterior cingulate cortex
- Open Access
- 8 June 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1856069
Pain-free survival after endoscopic neurotomy versus radiofrequency ablation of the C2 dorsal root ganglion for cervicogenic headache: a real-world comparison study
Background: Cervicogenic headache (CEH) is commonly treated with radiofrequency ablation (RFA) targeting the C2 dorsal root ganglion (DRG), yet the durability of analgesia is often limited. Endoscopic neurotomy (EN) enables direct visualization of the target neural structures and may provide more sustained pain relief; however, supporting evidence remains limited. We compared long-term outcomes of EN versus RFA targeting the C2 DRG in CEH. Methods: Patients with a positive diagnostic C2 DRG block were treated with EN or RFA. The Numerical Rating Scale (NRS), EuroQol 5-Dimension 5-Level (EQ-5D-5L), and Patient Global Impression of Change (PGIC) were obtained at baseline, and at 3 and 12 months postoperatively. The pain-free duration was recorded at every follow-up. The final follow-up was conducted in January 2026. Results: Of 76 included patients, 21 underwent EN and 55 underwent RFA. Both groups demonstrated significant reductions in NRS and improvements in EQ-5D-5L at 3 and 12 months postoperatively compared with baseline ( P < 0.001). NRS and EQ-5D-5L outcomes were comparable between groups at 3 months ( P > 0.05), whereas EN showed superior effectiveness at 12 months ( P < 0.05). PGIC favored EN at both 3 and 12 months ( P < 0.05). No serious adverse events were observed in either group, although occipital-distribution numbness occurred in 21/21 (100%) EN patients and 48/55 (87.3%) RFA patients. Median pain-free duration was 33 months in the EN group and 8 months in the RFA group ( P < 0.05). Conclusions: In this retrospective cohort, both EN and RFA improved pain and quality of life in clinically selected patients with CEH. EN was associated with longer pain-free duration; however, given its invasiveness and the diagnostic overlap between CEH and occipital neuralgia, EN should be considered cautiously as an escalation option in carefully evaluated patients.
- 8 June 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1856069
Open AccessPain-free survival after endoscopic neurotomy versus radiofrequency ablation of the C2 dorsal root ganglion for cervicogenic headache: a real-world comparison study
Background: Cervicogenic headache (CEH) is commonly treated with radiofrequency ablation (RFA) targeting the C2 dorsal root ganglion (DRG), yet the durability of analgesia is often limited. Endoscopic neurotomy (EN) enables direct visualization of the target neural structures and may provide more sustained pain relief; however, supporting evidence remains limited. We compared long-term outcomes of EN versus RFA targeting the C2 DRG in CEH. Methods: Patients with a positive diagnostic C2 DRG block were treated with EN or RFA. The Numerical Rating Scale (NRS), EuroQol 5-Dimension 5-Level (EQ-5D-5L), and Patient Global Impression of Change (PGIC) were obtained at baseline, and at 3 and 12 months postoperatively. The pain-free duration was recorded at every follow-up. The final follow-up was conducted in January 2026. Results: Of 76 included patients, 21 underwent EN and 55 underwent RFA. Both groups demonstrated significant reductions in NRS and improvements in EQ-5D-5L at 3 and 12 months postoperatively compared with baseline ( P < 0.001). NRS and EQ-5D-5L outcomes were comparable between groups at 3 months ( P > 0.05), whereas EN showed superior effectiveness at 12 months ( P < 0.05). PGIC favored EN at both 3 and 12 months ( P < 0.05). No serious adverse events were observed in either group, although occipital-distribution numbness occurred in 21/21 (100%) EN patients and 48/55 (87.3%) RFA patients. Median pain-free duration was 33 months in the EN group and 8 months in the RFA group ( P < 0.05). Conclusions: In this retrospective cohort, both EN and RFA improved pain and quality of life in clinically selected patients with CEH. EN was associated with longer pain-free duration; however, given its invasiveness and the diagnostic overlap between CEH and occipital neuralgia, EN should be considered cautiously as an escalation option in carefully evaluated patients.
- Open Access
- 8 December 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (23)
Covered stent implantation for intraoperative vertebral artery injury during posterior endoscopic cervical discectomy: illustrative case
BACKGROUND: Posterior endoscopic cervical discectomy (PECD) is a minimally invasive procedure with no published reported case of intraoperative vertebral artery injury (VAI) to date. OBSERVATIONS: This report describes a case of VAI during PECD managed with emergency extension of the incision for tamponade hemostasis, followed by endovascular intervention to restore vascular integrity and spinal canal decompression subsequently, resulting in a satisfactory recovery for the patient. LESSONS: PECD carries the risk of intraoperative VAI. Extending the incision for hemostasis, endovascular intervention for revascularization, and spine lamina decompression help prevent three critical complications: hemorrhagic shock, posterior circulation ischemia, and spinal cord injury. https://thejns.org/doi/10.3171/CASE24809
- 8 December 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (23)
Open AccessCovered stent implantation for intraoperative vertebral artery injury during posterior endoscopic cervical discectomy: illustrative case
BACKGROUND: Posterior endoscopic cervical discectomy (PECD) is a minimally invasive procedure with no published reported case of intraoperative vertebral artery injury (VAI) to date. OBSERVATIONS: This report describes a case of VAI during PECD managed with emergency extension of the incision for tamponade hemostasis, followed by endovascular intervention to restore vascular integrity and spinal canal decompression subsequently, resulting in a satisfactory recovery for the patient. LESSONS: PECD carries the risk of intraoperative VAI. Extending the incision for hemostasis, endovascular intervention for revascularization, and spine lamina decompression help prevent three critical complications: hemorrhagic shock, posterior circulation ischemia, and spinal cord injury. https://thejns.org/doi/10.3171/CASE24809
- Open Access
- 4 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 193, 223
Revision Surgery of Microvascular Decompression for Hemifacial Spasm: 2-Dimensional Operative Video
- 4 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 193, 223
Open AccessRevision Surgery of Microvascular Decompression for Hemifacial Spasm: 2-Dimensional Operative Video
- Open Access
- 1 October 2024
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 17, 3297-3311
Bidirectional Two-Sample Mendelian Randomization Analysis Reveals Causal Associations Between Modifiable Risk Factors and Fibromyalgia
Introduction: This study aims to investigate the potential causal effects of modifiable risk factors on Fibromyalgia (FM). Methods: Genetic variants associated with 34 exposure factors were obtained from Genome-wide association studies (GWAS). Summary statistics for FM were acquired from the FinnGen consortium. Bidirectional Mendelian randomization (MR) analysis was conducted between all exposures and outcomes. The inverse-variance weighted (IVW) method was employed as the primary estimation technique. Heterogeneity and pleiotropy were assessed using MR-PRESSO global test, the weighted median, Cochran’s Q statistic and MR-Egger. Results: Depression (OR=2.087, 95% CI: 1.466– 2.971), alcohol consumption (OR=1.489, 95% CI: 1.094– 2.028), body fat percentage (OR=1.524, 95% CI: 1.153– 2.013) and body mass index (BMI) (OR=1.542, 95% CI: 1.271– 1.872) were associated with an increased risk of FM among genetically susceptible individuals. Conversely, higher education level (OR=0.404, 95% CI: 0.297– 0.549), longer years of education (OR=0.489, 95% CI: 0.290– 0.825) and higher household income (OR=0.328, 95% CI: 0.215– 0.502) were protective against FM. Additionally, rheumatoid arthritis (OR=1.138, 95% CI: 1.061– 1.221) and ankylosing spondylitis (OR=1.079, 95% CI: 1.021– 1.140) were identified as important risk factors for FM. Conclusion: This MR study unveiled a complex causal relationship between modifiable risk factors and FM. Psychosocial factors significantly increase the odds of FM, while obesity and some autoimmune diseases that frequently coexist with FM demonstrate causal associations. Additionally, lifestyle habits such as alcohol consumption are causally related to FM. Further investigation is needed to determine whether risk factors contribute to the pathogenesis of FM through mechanisms involving central sensitization, inflammatory, and hyperalgesia. This study enhances our understanding of the factors that drive FM onset and progression, offering valuable insights for future targeted prevention and treatment strategies.
- 1 October 2024
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 17, 3297-3311
Open AccessBidirectional Two-Sample Mendelian Randomization Analysis Reveals Causal Associations Between Modifiable Risk Factors and Fibromyalgia
Introduction: This study aims to investigate the potential causal effects of modifiable risk factors on Fibromyalgia (FM). Methods: Genetic variants associated with 34 exposure factors were obtained from Genome-wide association studies (GWAS). Summary statistics for FM were acquired from the FinnGen consortium. Bidirectional Mendelian randomization (MR) analysis was conducted between all exposures and outcomes. The inverse-variance weighted (IVW) method was employed as the primary estimation technique. Heterogeneity and pleiotropy were assessed using MR-PRESSO global test, the weighted median, Cochran’s Q statistic and MR-Egger. Results: Depression (OR=2.087, 95% CI: 1.466– 2.971), alcohol consumption (OR=1.489, 95% CI: 1.094– 2.028), body fat percentage (OR=1.524, 95% CI: 1.153– 2.013) and body mass index (BMI) (OR=1.542, 95% CI: 1.271– 1.872) were associated with an increased risk of FM among genetically susceptible individuals. Conversely, higher education level (OR=0.404, 95% CI: 0.297– 0.549), longer years of education (OR=0.489, 95% CI: 0.290– 0.825) and higher household income (OR=0.328, 95% CI: 0.215– 0.502) were protective against FM. Additionally, rheumatoid arthritis (OR=1.138, 95% CI: 1.061– 1.221) and ankylosing spondylitis (OR=1.079, 95% CI: 1.021– 1.140) were identified as important risk factors for FM. Conclusion: This MR study unveiled a complex causal relationship between modifiable risk factors and FM. Psychosocial factors significantly increase the odds of FM, while obesity and some autoimmune diseases that frequently coexist with FM demonstrate causal associations. Additionally, lifestyle habits such as alcohol consumption are causally related to FM. Further investigation is needed to determine whether risk factors contribute to the pathogenesis of FM through mechanisms involving central sensitization, inflammatory, and hyperalgesia. This study enhances our understanding of the factors that drive FM onset and progression, offering valuable insights for future targeted prevention and treatment strategies.
- 16 April 2024
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (5) , 1555-1560
Safety and efficacy of endoscope-assisted versus microscopic microvascular decompression surgery for hemifacial spasm: a prospective cohort study
Microscopic microvascular decompression (M-MVD) is a classical treatment for relieving long-term hemifacial spasms (HFS). An endoscopy technique has recently been introduced to improve M-MVD; however, this application remains debatable. This study compared the safety and effectiveness of endoscope-assisted microvascular decompression (EA-MVD) and M-MVD for HFS. From February 2021 to September 2022, we enrolled 49 patients with HFS assigned to the EA-MVD (n = 26) and M-MVD (n = 23) groups. The patients were assessed with Park YS grades, operative time, hospital days, and complications. Evaluations were performed in the early postoperative period, at one month, 3 months, 6 months, and at least 12 months. Twenty-three (23/26, 88.5%) patients in the EA-MVD group and 20 (20/23, 87.0%) patients in the M-MVD group achieved spasm-free relief, ranging over “excellent” and “good” Park YS grades. The operative time in the EA-MVD and M-MVD groups were 143 ± 28 min and 145 ± 22 min (p = 0.002). The duration of hospital stay was 6.8 ± 0.8 days and 7.2 ± 1.3 days in the EA-MVD and M-MVD groups (p = 0.002), respectively. All surgeries for HFS were successful, with no death, stroke, hearing loss, facial numbness, or other extreme complications. In conclusion, EA-MVD, compared with M-MVD, demonstrated equally effective outcomes with decreased operative time and hospital stays, providing bright intraoperative illumination and flexible surgical vision.
- 16 April 2024
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (5) , 1555-1560
Safety and efficacy of endoscope-assisted versus microscopic microvascular decompression surgery for hemifacial spasm: a prospective cohort study
Microscopic microvascular decompression (M-MVD) is a classical treatment for relieving long-term hemifacial spasms (HFS). An endoscopy technique has recently been introduced to improve M-MVD; however, this application remains debatable. This study compared the safety and effectiveness of endoscope-assisted microvascular decompression (EA-MVD) and M-MVD for HFS. From February 2021 to September 2022, we enrolled 49 patients with HFS assigned to the EA-MVD (n = 26) and M-MVD (n = 23) groups. The patients were assessed with Park YS grades, operative time, hospital days, and complications. Evaluations were performed in the early postoperative period, at one month, 3 months, 6 months, and at least 12 months. Twenty-three (23/26, 88.5%) patients in the EA-MVD group and 20 (20/23, 87.0%) patients in the M-MVD group achieved spasm-free relief, ranging over “excellent” and “good” Park YS grades. The operative time in the EA-MVD and M-MVD groups were 143 ± 28 min and 145 ± 22 min (p = 0.002). The duration of hospital stay was 6.8 ± 0.8 days and 7.2 ± 1.3 days in the EA-MVD and M-MVD groups (p = 0.002), respectively. All surgeries for HFS were successful, with no death, stroke, hearing loss, facial numbness, or other extreme complications. In conclusion, EA-MVD, compared with M-MVD, demonstrated equally effective outcomes with decreased operative time and hospital stays, providing bright intraoperative illumination and flexible surgical vision.